Riskpilot← Back to searchSign inGet full accessInstant Infusion AB
ABActiveOrg 5566471214Skeppsgatan 19 3trBusiness and other management consultancy activities · NACE 7020Est. 20031-4 employees
Revenue 2025
SEK 714K
-19% vs 2024
EBITDA margin
-9.2%
+81% vs 2024
Equity ratio
68.1%
Financial strength
Net profit 2025
SEK -41K
+49% vs 2024
| Revenue | SEK 714K | -19% |
| EBITDA | SEK -66K | +81% |
| Net profit | SEK -41K | +49% |
| Total assets | SEK 260K | -26% |
| Equity | SEK 177K | -19% |
| Employees | — | — |
Legal name
Instant Infusion AB
Org number
5566471214
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
4 augusti 2003
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva - Försäljning, konsultation och service inom områdena organisation, ledarskap, förändring, projektledning och personlig utveckling, - Nätverksmarknadsföring av resor och investeringar, handel och förvaltning av värdepapper och andra finansiella instrument, - Samt idka därmed förenlig verksamhet.
Address
Skeppsgatan 19 3tr
Email
annette@inin.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 906 | 1 398 | 1 354 | 884 | 714 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 159 | 420 | 322 | −342 | −66 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 159 | 420 | 322 | −342 | −66 |
| Net financials | — | −1 | 1 | −260 | 25 |
| Profit before tax | 159 | 418 | 234 | −80 | −41 |
| Tax | −37 | −92 | −54 | −0 | −0 |
| Net profit | 122 | 326 | 180 | −80 | −41 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 520 | 1 163 | 1 074 | 351 | 260 |
| Equity | 941 | 517 | 498 | 218 | 177 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 274 | 341 | 183 | 133 | 83 |
| Total debt | 274 | 341 | 183 | 133 | 83 |
EBITDA margin
-9.2%
This company
15.8%
Market median
-158% vs market
20212025
Equity ratio
68.1%
This company
38.2%
Market median
+78% vs market
20212025
Return on equity
-23.2%
This company
18.4%
Market median
-226% vs market
20212025
Net profit margin
-5.7%
This company
8.1%
Market median
-170% vs market
20212025
Asset turnover
2.75×
This company
1.12×
Market median
+146% vs market
20212025
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Instant Infusion AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Annette Marie Wendin | Board of Directors | 0 companies |
| Lina Elsa Marie Haraldsson | Deputy Board Member | 0 companies |
| Ritva Gisela Rosenbäck | Deputy Board Member | 0 companies |